Vertex Pharmaceuticals Incorporated’s $10B Crinetics Pharmaceuticals, Inc. buy adds PALSONIFY & a Phase 3 CAH asset. Click ...

Vertex Pharmaceuticals Incorporated VRTX on Monday agreed to acquire Crinetics Pharmaceuticals Inc. CRNX for $85 per share in ...

R&D wins beyond cystic fibrosis, with the povetacicept FDA decision coming for IgA nephropathy. Click for this VRTX update.

David Meek bought the company last year for the pharma industry equivalent of loose change. The company was on the brink of ...

Geely has introduced a new entry-level SUV product in South Africa. Here's what you get for your money: ...

When you send a prompt to an AI provider, something happens to that text before the response arrives. Most providers store it ...

Explore how Hindu mythology shaped Western fantasy, from multiverses and cosmic cycles to avatars, magic systems, dragons, ...

PC gaming has undergone several graphical quantum leaps in its rich history, thanks to 3dfx, Nvidia, AMD, and even IBM. Here ...

This price reflects trading activity during the overnight session on the Blue Ocean ATS, available 8 PM to 4 AM ET, Sunday through Thursday, when regular markets are closed. The above button links to ...

Vertex Pharma could be close to succeeding in the long-standing quest to find an alternative to potentially addictive opioids for the treatment of pain associated with common medical procedures.

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.